Authors
Latest:
The Case for Establishing a Residency Program in Specialty PharmacyPharmacy residency programs offer postgraduate training to launch pharmacists from their formal education into successful careers.
Latest:
Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionPharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.
Latest:
Guidelines for Collaboration Among Physicians, Pharmacists, and Managed Care Organizations to Improve Asthma OutcomesNew ideas, new tools, and new collaborations among managed care, physicians, and pharmacy to optimize value in asthma management.
Latest:
Scott Gottlieb May be Selected to Head FDAExpedited drug approvals may become a reality if Scott Gottlieb confirmed as head of FDA.
Latest:
Recent Prosecutions on Product Discounts Show Legal Risk Hidden Beneath the SurfaceRecent prosecutions have heightened the risk for both market share discounts and discounts in lieu of service fees.
Latest:
Generic Product News: MarchProducts include oral suspension for gout and tablets that prevent low carnitine levels in the blood.
Latest:
Augmented Renal Clearance and the Impact on Antimicrobial TherapyWhether practicing pharmacy in the ambulatory or inpatient setting, professionals devote a substantial amount of energy and time to appropriate dosing of medications for renal impairment.
Latest:
Melatonin: Considerations for Use in Patients With Sleep DisordersMelatonin, an endogenous, or natural, hormone mainly produced by the pineal gland in the brain, regulates several body processes, including circadian rhythm and sleep patterns.
Latest:
Guselkumab Shows Efficacy as Active Psoriatic Arthritis TreatmentData from 2 studies evaluating guselkumab (Tremfya, Janssen) in active psoriatic arthritis were presented at the American College of Rheumatology and Association of Rheumatology Professionals 2019 Annual Meeting.
Latest:
Impact of Drug Therapy Duration in Patients With Hepatitis CAdherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Latest:
Cracking the Code of Optimized Influenza Prevention: Cell-Based Influenza Vaccine AdvancementCell-based vaccines have many potential advantages, one of which includes longer stability and more rapid manufacturing, as cellbased vaccines can be frozen and used at a later date, with dependable cell lines to ensure consistent supply.
Latest:
Cuvitru Approved for Primary ImmunodeficiencyThe FDA has just approved Shire's Cuvitru for primary immunodeficiency in patients 2 years and older.
Latest:
Relating to the Patient: My Most Influential ExperiencesA pharmacist offers her observations on patient-centered care.
Latest:
Lyme Vaccine Moves to Clinical TrialsThe FDA recently approved an Investigational New Drug application submitted by Valneva SE.
Latest:
When Will a Vaccine Be Ready?As we head into flu season, count on Pharmacy Times® to continue to report on the latest developments on COVID-19.
Latest:
Vaccination: What Do Consumers Want to Know?Researchers from Australia set out to determine health consumers' information needs and concerns related to childhood vaccination.
Latest:
Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty PharmacyThe National Association of Specialty Pharmacy's annual meeting is one of the industry’s only conferences where all stakeholders can fully participate.
Latest:
Long Acting Reversible Contraceptives and Chlamydia: No Increased RiskA team of researchers from Columbia University, New York City compared the incidence of chlamydia infection in adolescent LARC users to non-LARC users.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Reimagining Specialty Pharmacy: Market Variability Drives New StrategiesA common theme during this year’s summit was the uncertainty about the profitability of the existing specialty pharmaceutical model.
Latest:
Effect of Dispensing Supply on Pravastatin Refill AdherenceIn uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.
Latest:
The Value Potential of Biosimilars in the United StatesPharmacists must understand the potential value of biosimilars as a competitive generation of more cost efficient drugs hit the market.
Latest:
Leukemia: Causes, Symptoms, and TreatmentsLeukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.
Latest:
Making Sense of Allergic Rhinitis: A Pharmacist's Primer on General Overview and Treatment of Allergic RhinitisPharmacists can learn about current management of allergic rhinitis, including allergen avoidance, immunotherapy, and pharmacotherapy.
